Skip to main content
. 2020 Jun 12;13(7):1615–1626. doi: 10.1016/j.jcmg.2020.06.001

Table 2.

Exposure Risk and Needed PPE During Cardiovascular Imaging in the COVID-19 Era

CV Imaging
Procedure
Exposure
Type
Personal Protective Equipment
No Symptoms Suggestive of COVID-19 Confirmed/Suspected/Recovering COVID-19
Cardiovascular CT/CMR Droplet/contact Surgical mask + gloves Surgical mask + face shield
+ gown + gloves
Pharmacological stress (SPECT/PET/CMR) Droplet/contact Surgical mask + gloves Surgical mask + face shield
+ gown + gloves
TTE/pharmacological stress echocardiography Droplet with close contact (face-to-face) Surgical mask + face shield
+ gloves
Surgical mask + face shield
+ gown + gloves
Exercise test (SPECT/echocardiography/treadmill/MVO2) Possible aerosol generating N95 or N99 mask + face shield + appropriate surgical gown + gloves OR Reusable PAPR + surgical gown + gloves Alternate test recommended (or MVo2 postponed)
TEE Aerosol generating N95 or N99 mask + face shield + appropriate surgical gown + gloves OR Reusable PAPR + surgical gown + gloves N95 or N99 mask + face shield + appropriate surgical gown + gloves OR Reusable PAPR + surgical gown + gloves

CMR = cardiac magnetic resonance; CT = computed tomography; CV = cardiovascular; MVO2 = myocardial oxygen consumption during exercise; PAPR = powered air-purifying respirator; PET = positron emission tomography; SPECT = single-photon emission tomography; TTE = transthoracic echocardiography; other abbreviations as in Table 1.

For safety, test is best performed in a negative-pressure room with a good air exchange.

COVID-19 testing is currently at most 80% to 85% sensitive; an N95 or N99 mask or reusable PAPR is currently still advised for optimal protection.